President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad category of prescription drugs, handing the deep-pocketed pharmaceutical industry a major win as it lobbies aggressively against efforts to rein in its pricing power. Trump’s order, titled “Lowering Drug Prices by Once Again Putting Americans First,” instructs Health and Human…
This post has been syndicated from Truthout, where it was published under this address.